Antidepressant use and cognitive functioning in older medical patients with major or minor depression: A prospective cohort study with database linkage

Journal of Clinical Psychopharmacology

Volumn 31, Issue 4, 2011, Pages 429-435

  Han, Ling ^a,b   McCusker, Jane ^b,c   Cole, Martin ^b   Čapek, Radan ^b   Abrahamowicz, Michal ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MCGILL UNIVERSITY   (Canada)

^c ST MARY S HOSPITAL   (Canada)

Author keywords

antidepressant use; cognitive function; medical patients; minor depression; older persons

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE; CITALOPRAM; PAROXETINE; PSYCHOTROPIC AGENT; SERTRALINE;

AGED; ARTICLE; CANADA; COGNITION; COGNITIVE DEFECT; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DRUG USE; FEMALE; FOLLOW UP; HAMILTON SCALE; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HUMAN; LONG TERM DEPRESSION; LONG TERM EXPOSURE; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MINI MENTAL STATE EXAMINATION; PRESCRIPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS; BRIEF PSYCHIATRIC RATING SCALE; COGNITION DISORDERS; COHORT STUDIES; DATABASES, FACTUAL; DEPRESSIVE DISORDER; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PROSPECTIVE STUDIES;

EID: 79960570003     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0b013e318221b2f8     Document Type: Article

References (38)

1. Beekman ATF, Copeland JRM, Prince MJ. Review of community prevalence of depression in later life. Br J Psychiatry. 1999;174:307-311. (Pubitemid 29179713)
2. Lavretsky H, Kumar A. Clinically significant non-major depression: old concepts, new insights. Am J Geriatr Psychiatry. 2002;10:239-255. (Pubitemid 34517677)
3. Steffens DC, Otey E, Alexopoulos GS, et al. Perspectives on depression, mild cognitive impairment, and cognitive decline. Arch Gen Psychiatry. 2006;63:130-138. (Pubitemid 43213874)
4. Cole MG, Bellavance F, Mansour A. Prognosis of depression in elderly community and primary care populations: a systematic review and meta-analysis. Am J Psychiatry. 1999;156:1182-1189. (Pubitemid 29374877)
5. Beekman ATF, Deeg DJ, Braam AW, et al. Consequence of major and minor depression in later life: a study of disability, well-being, and service utilization. Psychol Med. 1997;27:1397-1409. (Pubitemid 27494105)
6. Lebowitz BD, Pearson JL, Schneider LS, et al. Diagnosis and treatment of depression in late life. Consensus statement update [Review]. JAMA. 1997;278:1186-1190. (Pubitemid 27422429)
7. Oxman TE, Sengupta A. Treatment of minor depression. Am J Geriat Psychiatry. 2002;10:256-264. (Pubitemid 34517678)
8. Snow V, Lascher S, Mottur-Pilson C. Pharmacological treatment of acute major depression and dysthymia. Ann Intern Med. 2000;132:738-742. (Pubitemid 30244175)
9. Ackermann RT, Williams JW. Rational treatment choices for non-major depressions in primary care. An evidence-based review. J Gen Intern Med. 2002;17:293-301. (Pubitemid 34415688)
10. Williams JW, Barrett J, Oxman T, et al. Treatment of dysthymia and minor depression in primary care. A randomized controlled trial in older adults. JAMA. 2000;284:1519-1526.
11. Oxman TE. Antidepressants and cognitive impairment in the elderly. J Clin Psychiatry. 1996;57:38-44. (Pubitemid 26182272)
12. Amado-Boccara I, Gougoulis N, Poirier Littre MF, et al. Effects of antidepressants on cognitive functions: a review [Review]. Neurosci Biobehav Reviews. 1995;19:479-493.
13. Lotrich F, Pollock BG. Aging and clinical pharmacology: implications for antidepressants. J Clin Pharmacol. 2005;45:1106-1122. (Pubitemid 41361911)
14. Fournier JC, DeRubeis RJ, Hollon SD, et al. Antidepressant drug effects and depression severity: a patient-level meta-analysis. JAMA. 2010;303:47-53.
15. Butters MA, Becker JT, Nebes RD, et al. Changes in cognitive functioning following treatment of late-life depression. Am J Psychiatry. 2000;157:1949-1954.
16. Doraiswamy PM, Krishnan RR, Oxman T, et al. Does antidepressant therapy improve cognition in elderly depressed patients? J Geront Series A Biol Sci Med Sci. 2003;58A:1137-1144. (Pubitemid 38018529)
17. Nebes RD, Pollock BG, Mulsant BH, et al. Cognitive effects of paroxetine in older depressed patients. J Clin Psychiatry. 1999;60(suppl 20):26-29. (Pubitemid 29468387)
18. Culang M, Sneed JR, Keilp JG, et al. Change in cognitive functioning after acute antidepressant treatment in late-life depression. Am J Geriatr Psychiatry. 2009;17:881-888.
19. Chew ML, Mulsant BH, Pollock BG, et al. Anticholinergic activity of 107 medications commonly used by older adults. J Am Geriatr Soc. 2008;56:1333-1341.
20. Vandenbroucke JP, Psaty BM. Benefits and risks of drug treatments: how to combine the best evidence on benefits with the best data about adverse effects. JAMA. 2008;300:2417-2419.
21. Cole MC, McCusker J, Dendukuri N, et al. Systematic detection and multidisciplinary care of depression in older medical inpatients: a randomized trial. CMAJ. 2006;174:38-44. (Pubitemid 43068896)
22. Han L, McCusker J, Cole M, et al. 12-month cognitive outcome of major and minor depression in older medical patients. Am J Geriatr Psychiatry. 2008;16:742-751.
23. Pfeiffer E. A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. J Am Geriatr Soc. 1975;23:433-441.
24. Robins LN, Helzer JE, Croughan J, et al. National Institute of Mental Health Diagnostic Interview Schedule. Its history, characteristics, and validity. Arch Gen Psychiatry. 1981;38:381-389. (Pubitemid 11156022)
25. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 1967;6:278-296.
26. Koenig HG, George LK, Peterson BL, et al. Depression in medically ill hospitalized older adults: prevalence, characteristics, and course of symptoms according to six diagnostic schemes. Am J Psychiatry. 1997;154:1376-1383. (Pubitemid 27415604)
27. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
28. Tombaugh TN, McIntyre NJ. The mini-mental state examination: a comprehensive review. [Review]. J Am Geriatr Soc. 1992;40:922-935.
29. Han L, Cole M, Bellavance F, et al. Tracking cognitive decline in Alzheimer's disease using the mini-mental state examination: a meta-analysis. Int Psychogeriatr. 2000;12:231-247. (Pubitemid 30490970)
30. Tamblyn B, Lovaie G, Petrella L, et al. The use of prescription claims databases in pharmacoepidemiological research: the accuracy and comprehensiveness of the prescription claims databases in Quebec. J Clin Epidemiol. 1995;48:999-1009.
31. American Society of Hospital Pharmacists. American Hospital Formulary Service. Drug information. Bethesda, MD: American Society of Hospital Pharmacists; 1994.
32. Paterniti S, Dufouil C, Alperovitch A. Long-term benzodiazepine use and cognitive decline in the elderly: the Epidemiology of Vascular Aging Study. J Clin Psychopharmacol. 2002;22:285-293. (Pubitemid 34546844)
33. Dealberto MJ, Mcavay GJ, Seeman T, et al. Psychotropic drug use and cognitive decline among older men and women. Int J Geriatr Psychiatry. 1997;12:567-574. (Pubitemid 27239061)
34. Han L, McCusker J, Cole M, et al. Use of medications with anticholinergic effect predicts clinical severity of delirium symptoms in older medical inpatients. Arch Intern Med. 2001;161:1099-1105. (Pubitemid 32685536)
35. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis. 1987;40:373-383. (Pubitemid 17055592)
36. Verbeke G, Molenberghs G. Linear Mixed Models for Longitudinal Data. New York, NY: Springer-Verlag New York, Inc.; 2000.
37. Steckler T, Sahgal A. The role of serotonergic-cholinergic interactions in the mediation of cognitive behavior. Behav Brain Res. 1995;67:165-199.
38. Perera TD, Park S, Nemirovskaya Y. Cognitive role of neurogenesis in depression and antidepressant treatment. Neuroscientist. 2008;14:326-338. (Pubitemid 352010067)